Simplify Logo

Full-Time

Principal Investigator

Pi, Cell & Gene Therapy

Posted on 7/10/2024

BioAgilytix

BioAgilytix

501-1,000 employees

Bioanalytical testing for drug development

Food & Agriculture
Data & Analytics
Hardware
Biotechnology
Healthcare

Expert

Durham, NC, USA

Category
Bioinformatics
Genomics
Biology & Biotech
Required Skills
Data Analysis
Google Cloud Platform
Requirements
  • BS with 10+ years, MS with 8+ years’, or PhD with 6+ years’ bioanalytical lab experience
  • Thorough knowledge of regulatory guidance and industry best practices
  • Experience with nucleic acid extraction and detection
  • Expertise in nucleic acid extraction, real-time PCR, digital droplet PCR, branched DNA assays, nanostring
  • Advanced capabilities in data analysis, data visualization statistical analysis
  • Previous management/supervisor experience
  • GDP, GLP, GCLP, GCP
  • Not less than two (2) years' experience in GxP environments
Responsibilities
  • Lead bioanalytical method development, validation, and sample analysis
  • Drive pre-clinical and clinical trial projects
  • Frequent communication with clients
  • Advise clients on PCR assay best practices
  • Author and review documents
  • Statistical analysis of PCR data
  • Work collaboratively to deliver high quality data
  • Mentor and supervise junior level Scientists

BioAgilytix provides specialized bioanalytical testing services for the pharmaceutical, biotechnology, and agricultural biotechnology industries. Their services include a variety of assays, such as pharmacokinetics (PK) and pharmacodynamics (PD) assays, which analyze how drugs behave in the body, as well as cell-based assays that test drug effects on living cells and immunogenicity assays that assess immune responses to drugs. With a laboratory in Hamburg, Germany, BioAgilytix operates globally and supports clients in developing and validating new treatments, ensuring the safety and efficacy of agricultural products, and has also contributed to COVID-19 testing efforts. Unlike many competitors, BioAgilytix focuses specifically on large molecule studies, making them a crucial partner for companies in the life sciences sector. Their goal is to facilitate the development and approval of new drugs and therapies through their comprehensive testing services.

Company Stage

Series A

Total Funding

$30.2M

Headquarters

Durham, North Carolina

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic partnerships, such as with BBI Solutions and A3P Biomedical, enhance BioAgilytix's service offerings and market reach.
  • Expansion of the Hamburg lab and the addition of new leadership positions indicate robust growth and investment in infrastructure and talent.
  • The company's role in COVID-19 testing and advanced diagnostics positions it as a critical player in addressing global health challenges.

What critics are saying

  • The cancellation of the $61.5 million expansion deal in Durham, which promised 878 jobs, could indicate potential financial or strategic setbacks.
  • High turnover in leadership, including the recent appointment of a new COO and VP of Business Development, may lead to strategic misalignments and operational disruptions.

What makes BioAgilytix unique

  • BioAgilytix specializes in large molecule studies, offering a comprehensive suite of assays that are critical for drug development, unlike competitors who may focus on small molecules.
  • Their global presence, particularly with a significant laboratory in Hamburg, Germany, allows them to support clients across multiple continents, providing a competitive edge in accessibility and reach.
  • The company's involvement in COVID-19 testing and partnerships with firms like A3P Biomedical for advanced diagnostics showcases their adaptability and commitment to addressing urgent healthcare needs.
INACTIVE